Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition characterized by painful lumps under the skin, often in areas where skin rubs together, such as the armpits, groin, and under the breasts. While it affects millions, it is frequently misunderstood and misdiagnosed. Unfortunately, this is one of many conditions that can be surrounded by myths and misconceptions. Let’s peel back the layers and uncover the real story behind HS, offering clarity and support to those impacted by this condition.
Many believe HS is rare, but it’s quite common and often underdiagnosed. Up to 4% of Canada’s population has HS, ranging from 300,000 to over a million individuals.
HS is frequently misdiagnosed as skin infections or ingrown hairs, which can lead to years without proper diagnosis and treatment. 8 out of 10 individuals are misdiagnosed with HS at least once. The average time to diagnosis is 8 years, which means many do not receive the correct treatment in the early stages of the disease.
HS is not contagious. It is a chronic inflammatory skin condition that does not spread from person to person. HS often starts as small, pea-sized bumps and can progress to larger abscesses that may rupture and leak pus, which may lead some people to believe it is infectious. In reality, this is caused by chronic skin inflammation that has led to tunnel formation under the skin, resulting in fluid drainage from these areas.
HS is not caused by poor hygiene. Over-cleaning and excessive scrubbing can worsen symptoms for some individuals. Scrubbing the skin with loofahs, brushes, or washcloths induces trauma to the skin, which can be a trigger to precipitate flares. However, using certain skin care products, such as specific antiseptic or antimicrobial washes, can reduce the number of flares and improve symptoms. If you are someone living with HS, it is important to speak with your healthcare practitioner or dermatologist for recommendations on a skincare routine that will work for you.
Exercise is one of the most beneficial lifestyle measures for managing HS flares and should not be avoided because of the condition. Exercise can promote circulation, reduce inflammation, and help clear toxins. If sweating worsens your symptoms, try exercising in cooler temperatures or adjusting your routine. This can help minimize discomfort while reaping health benefits from exercise.
While there is no cure for HS, many treatment options are available to manage symptoms, reduce flare-ups, and improve quality of life. Treatments include antibiotics, anti-androgen (hormonal) treatments, biological therapies, and anti-inflammatory medications. Early diagnosis and intervention are important to prevent the progression of the disease, so it is essential to speak with your dermatologist to determine what treatment plan is right for you.
HS impacts more than just the skin. The visible nature of the condition can lead to anxiety, depression, and social withdrawal. Aside from psychological impacts, HS is also associated with other medical conditions like inflammatory arthritis, inflammatory bowel disease, metabolic disorders, and polycystic ovary syndrome (PCOS).
Patients with HS may feel isolated and reluctant to talk about their condition. This can lead to feelings of shame and self-blame. However, if you are a patient with HS, you are not alone in this journey. There are excellent resources available that provide reliable information about HS, such as the Canadian Hidradenitis Suppurativa Foundation.
Many support groups are also available to connect with other individuals experiencing the same symptoms, such as Hidradenitis and Me.
By debunking these myths, we hope to raise awareness and provide support for those living with HS. If you or someone you know is struggling with HS, contact a healthcare professional for guidance and support.
References
doi:10.1016/j.jaad.2019.08.090
https://www.uptodate.com/contents/hidradenitis–suppurativa–pathogenesisclinical–features–and–
diagnosis?search=hidradenitis%20suppurativa%20&source=search_result&select edTitle=2~89&usage_type=default&display_rank=2
2023;13(1):189. doi:10.3390/life13010189
doi:10.1111/bjd.18135
Submitted by: Madeleine Crawford, MS4
Word Count: 661